Jerome Yates

He attended Lawrence University as an Undergraduate, the University of Illinois for medical school and Harvard University for an MPH. He was trained in medical oncology and is certified by the American College of Physician Executives.

Early in his oncology career he conducted studies of patients undergoing aggressive treatment or bone marrow transplantation for acute leukemia at Roswell Park Cancer Institute. The 7 & 3 therapy for AML was conducted and published in the early 70’s and was standard therapy for the next twenty + years. During that time he participated as an ACS volunteer speaking widely in Ohio, Pennsylvania and New York as well as National meetings.

For the next phase of his career he was in Vermont where he ran the clinical and cancer control services at the cancer center. He was instrumental in the development of the Request for Proposals and participated in the oversight of the study sponsored by both HCFA and the Robert Wood Johnson Foundation. He was a hospice physician at that time.

Then he went to the NCI to be the Associate Director for Centers and Community Oncology. He along with others developed the Community Clinical Oncology Program which now account for the majority of the accrual to the cooperative group clinical trials supported by the NCI. He also pushed for evaluation of the CCOPs and other NCI programs to generate information that could maximize the return on investment.

From there he returned to Roswell Park to be the Sr. V.P. for Clinical Affairs and also ran the prevention and cancer control programs. After 14 years he came to the American cancer society 3 years ago. Presently he is recruiting leadership for the BRC and adding new talent to the center for statistics and evaluation.

He has served on a variety of advisory committees for cancer centers in the US and internationally, he has served on a variety of peer review committees and has approximately 100 peer reviewed publications.